Form4insider filings, from the source

Company · CIK 0000894158 · SIC 2834 — Pharmaceutical Preparations · NYSE

Synthetic Biologics, Inc. · SYN

Insider activity reported against this company. All insider holders · On EDGAR ↗

1M3M6M1Y2YAll datashares as filed — not split-adjusted
Open-market buys & salesbuys $3.0M · 1sales $0 · 0net $3.0M
$10k$10k$100k$100k$1M$1M$10M$10MbuyssalesSep 1Sep 1Sep 1Sep 2Sep 2Sep 2Sep 3

Reported at this company — common stock

TradeReported (ET)InsiderSharesAvg priceTotalOwned afterΔ stakeFlags
Mar 14, 2017 MForm 4 →Mar 16, 6:52 pm EDTJeffrey J KrawsDirector228,773$0.09$20,590228,773— plan?
Nov 18, 2016 AForm 4 →Nov 18, 11:12 am ESTScott TarriffDirector300,000——300,000— plan?
Sep 2, 2015 PForm 4 →Sep 4, 2:24 pm EDTRandal J Kirk +110% Owner937,500$3.20$3,000,0009,613,268+10.8% plan?
Apr 1, 2015 MForm 4 →Apr 2, 3:06 pm EDTJeffrey Alan WolfDirector10,842$0.09$97610,842— plan?

Reported at this company — derivatives (options, RSUs, warrants)

TradeReported (ET)InsiderSharesAvg priceTotalOwned afterΔ stakeFlags
Dec 6, 2018 AForm 4 →Dec 7, 5:02 pm ESTJeffrey J KrawsDirector79,500——79,500—
Dec 6, 2018 AForm 4 →Dec 7, 5:02 pm ESTSteven A ShallcrossCEO and CFO, Director200,000——200,000—
Dec 6, 2018 AForm 4 →Dec 7, 5:01 pm ESTJeffrey Alan WolfDirector79,500——79,500—
Dec 6, 2018 AForm 4 →Dec 7, 5:01 pm ESTScott TarriffDirector79,500——79,500—
Dec 20, 2017 AForm 4 →Dec 21, 5:21 pm ESTSteven A ShallcrossInterim CEO and CFO550,000——550,000—
Dec 20, 2017 AForm 4 →Dec 21, 5:20 pm ESTJoseph A. SlimanChief Medical Officer410,000——410,000—
Dec 20, 2017 AForm 4 →Dec 21, 5:20 pm ESTJeffrey J KrawsDirector200,000——200,000—
Dec 20, 2017 AForm 4 →Dec 21, 5:20 pm ESTJeffrey Alan WolfDirector200,000——200,000—
Dec 20, 2017 AForm 4 →Dec 21, 5:18 pm ESTScott TarriffDirector200,000——200,000—
Mar 14, 2017 MForm 4 →Mar 16, 6:52 pm EDTJeffrey J KrawsDirector228,773——0—
Jan 17, 2017 AForm 4 →Jan 18, 5:08 pm ESTJoseph A. SlimanChief Medical Officer188,927——188,927—
Nov 30, 2016 AForm 4 →Dec 2, 5:07 pm ESTScott TarriffDirector168,750——168,750—
Nov 30, 2016 AForm 4 →Dec 2, 5:06 pm ESTJeffrey Scott RileyChief Executive Officer, Director1,129,000——1,129,000—
Nov 30, 2016 AForm 4 →Dec 2, 5:05 pm ESTJeffrey Alan WolfDirector168,750——168,750—
Nov 30, 2016 AForm 4 →Dec 2, 5:03 pm ESTJeffrey J KrawsDirector168,750——168,750—
Nov 30, 2016 AForm 4 →Dec 2, 5:02 pm ESTSteven A ShallcrossChief Financial Officer500,000——500,000—
Nov 18, 2016 AForm 4 →Nov 18, 11:12 am ESTScott TarriffDirector600,000——300,000—
Dec 4, 2015 AForm 4 →Dec 4, 8:13 pm ESTJeffrey J KrawsDirector125,000——125,000—
Dec 4, 2015 AForm 4 →Dec 4, 8:12 pm ESTScott TarriffDirector125,000——125,000—
Dec 4, 2015 AForm 4 →Dec 4, 8:12 pm ESTJeffrey Alan WolfDirector125,000——125,000—
Dec 4, 2015 AForm 4 →Dec 4, 8:11 pm ESTSteven A ShallcrossChief Financial Officer100,000——100,000—
Dec 4, 2015 AForm 4 →Dec 4, 8:11 pm ESTJeffrey Scott RileyChief Executive Officer, Director500,000——500,000—
Jun 1, 2015 AForm 4 →Jun 1, 4:56 pm EDTSteven A ShallcrossChief Financial Officer900,000——900,000—
Apr 1, 2015 MForm 4 →Apr 2, 3:06 pm EDTJeffrey Alan WolfDirector10,842——0—
Jan 8, 2015 AForm 4 →Jan 12, 6:11 am ESTCharles Evan BallantyneChief Financial Officer200,000——200,000—
Jan 8, 2015 AForm 4 →Jan 12, 6:09 am ESTJeffrey Scott RileyCEO and President, Director350,000——350,000—